---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-025720"
form_type: "8-K"
ticker: "IVF"
cik: "0001417926"
company_name: "INVO Fertility, Inc."
filed_at: "2023-07-27T23:59:59+00:00"
generated_at: "2026-06-13T00:13:56.212923+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# INVO Bioscience 1-for-20 reverse stock split effective July 28; Nasdaq panel grants continued listing until Sept 29

## Summary
- Reverse split every 20 shares into 1; effective 12:01 a.m. ET July 28, 2023; trading symbol unchanged (INVO).
- Post-split shares outstanding ~842,017; authorized shares reduced to 6,250,000; fractional shares rounded up.
- Nasdaq Hearings Panel granted continued listing subject to compliance with $1.00 bid price and $2.5M equity by Sept 29, 2023.
- Reverse split intended to regain Nasdaq minimum bid price compliance; no assurance of success.
- Company previously non-compliant with bid price and equity requirements; July 6 hearing discussed.

## SEC filing metadata
- accession: 0001493152-23-025720
- form_type: 8-K
- ticker: IVF
- cik: 0001417926
- company_name: INVO Fertility, Inc.
- filed_at: 2023-07-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417926/000149315223025720/0001493152-23-025720-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417926/000149315223025720/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-025720
- JSON: https://secwatch.observer/filing/0001493152-23-025720.json
- Plain text: https://secwatch.observer/filing/0001493152-23-025720.txt

## Key facts
- Governance Changes
  INVO Fertility, Inc.: Effected a 1-for-20 reverse stock split of common stock, adjusting authorized shares to 6,250,000 (effective 2023-07-28).
  - Change: charter amendment
  - Effective: 2023-07-28
  source text: On July 26, 2023, INVO Bioscience, Inc. (the “Company”) filed a Certificate of Change (the “Certificate of Change”) with the Secretary of State of the State of Nevada to effectuate a 1-for-20 reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding and authorized shares of common stock, par value $0.0001 per share (“Common Stock”). The Reverse Stock Split will become effective at 12:01 a.m., Eastern Time, on Friday, July 28, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417926/000149315223025720/0001493152-23-025720-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.